Menora Mivtachim Holdings’s UroGen Pharma URGN Stock Holding History

Menora Mivtachim Holdings’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.7M	Hold	1,152,531	–	–	0.1%	90
2025 Q4	$27M	Hold	1,152,531	–	–	0.13%	74
2025 Q3	$23M	Hold	1,152,531	–	–	0.12%	76
2025 Q2	$15.8M	Sell	1,152,531 -1,150,500	-50%	-$11M	0.09%	77
2025 Q1	$25.5M	Hold	2,303,031	–	–	0.17%	71
2024 Q4	$24.5M	Hold	2,303,031	–	–	0.15%	64
2024 Q3	$29.2M	Hold	2,303,031	–	–	0.18%	57
2024 Q2	$38.6M	Hold	2,303,031	–	–	0.26%	59
2024 Q1	$34.5M	Hold	2,303,031	–	–	0.26%	56
2023 Q4	$34.5M	Hold	2,303,031	–	–	0.29%	57
2023 Q3	$32.3M	Sell	2,303,031 -226,789	-9%	-$3.64M	0.29%	58
2023 Q2	$26.2M	Sell	2,529,820 -389,183	-13%	-$4.29M	0.24%	58
2023 Q1	$27M	Hold	2,919,003	–	–	0.28%	56
2022 Q4	$25.9M	Hold	2,919,003	–	–	0.44%	39
2022 Q3	$24.3M	Sell	2,919,003 -30,486	-1%	-$252K	0.46%	36
2022 Q2	$24.2M	Sell	2,949,489 -3,000	-0.1%	-$20.6K	0.44%	37
2022 Q1	$25.7M	Hold	2,952,489	–	–	0.37%	38
2021 Q4	$28.1M	Sell	2,952,489 -2,210	-0.1%	-$31.2K	0.38%	41
2021 Q3	$49.7M	Hold	2,954,699	–	–	0.73%	39
2021 Q2	$45.1M	Hold	2,954,699	–	–	0.65%	39
2021 Q1	$57.6M	Hold	2,954,699	–	–	0.94%	36
2020 Q4	$53.2M	Hold	2,954,699	–	–	0.93%	37
2020 Q3	$57M	Hold	2,954,699	–	–	1.27%	37
2020 Q2	$77.2M	Hold	2,954,699	–	–	1.89%	27
2020 Q1	$52.7M	Hold	2,954,699	–	–	1.44%	32
2019 Q4	$98.6M	Hold	2,954,699	–	–	2.35%	14
2019 Q3	$70.4M	Hold	2,954,699	–	–	1.71%	34
2019 Q2	$106M	Hold	2,954,699	–	–	2.87%	8
2019 Q1	$109M	Buy	2,954,699 +454,829	+18%	+$19.1M	2.93%	3
2018 Q4	$108M	Hold	2,499,870	–	–	3.11%	3
2018 Q3	$118M	Hold	2,499,870	–	–	3.2%	3
2018 Q2	$124M	Buy	2,499,870 +454,241	+22%	+$26.4M	3.53%	4
2018 Q1	$102M	Buy	2,045,629 +535,622	+35%	+$26.8M	3.22%	5
2017 Q4	$56.2M	Buy	1,510,007 +940,418	+165%	+$33.5M	2.17%	9
2017 Q3	$18M	Buy	569,589 +440,534	+341%	+$9.72M	0.73%	52
2017 Q2	$2.33M	Buy	+129,055	New	+$2.24M	0.11%	58